Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of LC16m8 Smallpox Vaccine in Healthy Volunteers
NCT00103584Phase 2Unknown
- Sponsor
- diadexus
- Start
- Oct 2004
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of lc16m8 in smallpox, sponsored by diadexus. Status: unknown.
02
Drugs
lc16m8
03
Conditions
smallpox
Beyond the preview
Go deeper on NCT00103584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103584.